Bilirubin and amyotrophic lateral sclerosis [2] (multiple letters)

Clinical Neurology and Neurosurgery

Volumn 107, Issue 2, 2005, Pages 160-161

  Iwasaki, Yasuo ^a   Igarashi, Osamu ^a   Iwasa, Yoshiaki ^a   Hirano, Kiyoko ^a   Satoh, Ryuta ^a   Iwamoto, Kounosuke ^a   Kawase, Yuji ^a   Aoyagi, Joe ^a   Ichikawa, Yasumitsu ^a   Kawabe, Kiyokazu ^a   Ikeda, Ken ^a   Iłzecka, Joanna ^b   Stelmasiak, Zbigniew ^b  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BILIRUBIN;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BILIRUBIN BLOOD LEVEL; BLOOD SAMPLING; BRAIN NERVE CELL; CELL MATURATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID ANALYSIS; CORRELATION COEFFICIENT; DISEASE DURATION; DISEASE MODEL; DISEASE SEVERITY; ETHNIC GROUP; EXCITOTOXICITY; HEMATOLOGIC DISEASE; HEMOCONCENTRATION; HUMAN; HYPOXIA; LETTER; LIVER DISEASE; MEASUREMENT; MOTONEURON; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATIENT; STATISTICAL SIGNIFICANCE; SURVIVAL; TRANSGENIC MOUSE;

EID: 13644252980     PISSN: 03038467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clineuro.2004.07.008     Document Type: Article

References (4)

1. J. Hzecka Z. Stelmasiak Serum bilirubin concentration in patients with amyotrophic lateral sclerosis Clin Neurol Neurosurg 105 2003 237 240
2. A.C. Ludolph T. Meyer M.W. Riepe The role of excitotoxiaty in ALS – what is the evidence? J Neurol 2471 Suppl. 1 2000 7 16
3. Y. Iwasaki K. Ikeda M. Kinoshita Molecular and cellular mechanism of glutamate receptors in relation to amyotrophic lateral sclerosis Curr. Drug Targets–CNS Neurol Dis 1 2002 511 518
4. Y. Iwasaki K. Ikeda M. Kinoshita Vitamin A and E levels are normal in amyotrophic lateral sclerosis J Neurol Sci 132 1995 193 194